Hence then, the article about innovent announces phase 2 clinical study of picankibart ibi112 in chinese patients with ulcerative colitis met primary endpoint was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Innovent Announces Phase 2 Clinical Study of Picankibart (IBI112) in Chinese Patients with Ulcerative Colitis Met Primary Endpoint )
Last updated :
Also on site :
- Art Garfunkel Makes Surprise Return to Madison Square Garden with Charlie Puth in Special Performance of "The Boxer"
- ‘The Birds’ Limited Series Starring Sarah Snook Hits TV Marketplace; New Take On Hitchcock’s Classic Comes From Tom Spezialy, David Heyman & UIS
- Hydro One seeks approval from the Ontario Energy Board to build the Orléans Area Reinforcement Project